Why Partner With DPG?

IN-LICENSE:

Trusted partner to commercialize branded and generic products for patients in the Canadian and/or U.S. marketplace:

• Six separate companies, focused on women's health, rare diseases, brand and generic treatment options
• Expertise in sales and marketing, pricing, market access, regulatory and legal affairs in the U.S. and Canada to meet patients' needs
• Life-cycle management capabilities for long-term product success
• Entrepreneurial spirit and culture: agile, focused, and efficient

OUT-LICENSE:

Duchesnay also out-licenses its in-house developed, manufactured and patented treatment portfolio for nausea and vomiting of pregnancy (NVP) in over 40 countries. This unique product portfolio features two formulations that combine doxylamine succinate and pyridoxine hydrochloride and is available under different strengths and formulations.